KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,732 | -9.5% | 3,589 | +5.0% | 0.00% | 0.0% |
| Q2 2023 | $36,152 | -9.1% | 3,417 | +5.0% | 0.00% | 0.0% |
| Q1 2023 | $39,784 | +9.4% | 3,253 | +11.0% | 0.00% | 0.0% |
| Q4 2022 | $36,374 | -9.1% | 2,931 | +0.4% | 0.00% | 0.0% |
| Q3 2022 | $40,000 | -24.5% | 2,920 | +1.1% | 0.00% | -50.0% |
| Q2 2022 | $53,000 | +8.2% | 2,887 | -5.3% | 0.00% | +100.0% |
| Q1 2022 | $49,000 | +19.5% | 3,047 | +4.2% | 0.00% | 0.0% |
| Q4 2021 | $41,000 | -24.1% | 2,925 | +1.3% | 0.00% | -50.0% |
| Q3 2021 | $54,000 | -10.0% | 2,887 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $60,000 | -26.8% | 2,887 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $82,000 | -12.8% | 2,887 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $94,000 | – | 2,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |